Derivation of human induced pluripotent stem cell (iPSC) line from a 79 year old sporadic male Parkinson's disease patient

Derivation of human induced pluripotent stem cell (iPSC) line from a 79 year old sporadic male Parkinson's disease patient

Peripheral blood was collected from a clinically diagnosed 79-year old male sporadic Parkinson's disease patient. Peripheral blood mononuclear cells (PBMCs) were reprogrammed with the Yamanaka KMOS reprogramming factors using the Sendai-virus reprogramming system. The transgene-free iPSC line s...

Full description

Bibliographic Details
Main Authors:	Shaokun Zhang, Lidi Liu, Yang Hu, Zhenshan Lv, Qiao Li, Weiquan Gong, Hui Sha, Hong Wu
Format:	Article
Language:	English
Published:	Elsevier 2017-03-01
Series:	Stem Cell Research
Online Access:	http://www.sciencedirect.com/science/article/pii/S1873506116302264

Similar Items

Generation of a human induced pluripotent stem cell (iPSC) line from a 64 year old male patient with multiple schwannoma
by: Shaokun Zhang, et al.
Published: (2017-03-01)

Characterization of human induced pluripotent stem cell (iPSC) line from a 72 year old male patient with later onset Alzheimer's disease
by: Shaokun Zhang, et al.
Published: (2017-03-01)

Development of human induced pluripotent stem cell (iPSC) line from a 60 year old female patient with multiple schwannoma
by: Shaokun Zhang, et al.
Published: (2017-03-01)

Characterization of human induced pluripotent stem cells line JLUEYEi002-A from a 48 year old healthy male
by: Hong Wu, et al.
Published: (2021-05-01)

Generation and characterization of human induced pluripotent stem cells line JLUEYEi001-A from a 45 year old female with Stickler syndrome
by: Hong Wu, et al.
Published: (2021-05-01)

Establishment of induced pluripotent stem cell (iPSC) line from a 57-year old patient with sporadic Alzheimer's disease
by: Anna Ochalek, et al.
Published: (2016-07-01)

Generation and characterization of a human induced pluripotent stem cell (iPSC) line (HEBHMUi001-A) from a sporadic Parkinson's disease patient
by: Jun Ma, et al.
Published: (2019-04-01)

Establishment of an induced pluripotent stem cell (iPSC) line from a 9-year old male with autism spectrum disorder (ASD)
by: Eszter Varga, et al.
Published: (2017-05-01)

Three dimensional collagen scaffolds promote iPSC induction with higher pluripotency
by: Qi Gu, et al.
Published: (2016-10-01)

Generation of gene-corrected iPSC line from Parkinson's disease patient iPSC line with alpha-SNCA A53T mutation
by: Seo-Young Lee, et al.
Published: (2018-07-01)

Testing and Application Oxidative Stress on Induced Pluripotent Stem Cell (iPSC) Platform
by: Kuan-Hsuan Chen, et al.
Published: (2016)

The core mammalian pluripotency network in induced pluripotent stem cell (iPSC) formation : models for genetic and epigenetic reprogramming
by: Abdallah, Hussein(Hussein M.)
Published: (2019)

The CIRM iPSC repository
by: Stephen S. Lin, et al.
Published: (2020-04-01)

CiRA iPSC seed stocks (CiRA's iPSC Stock Project)
by: Tadaaki Hanatani, et al.
Published: (2021-01-01)

Modelling of amyotrophic lateral sclerosis (ALS) using induced pluripotent stem cells (iPSC)
by: Ababneh, Nidaa
Published: (2017)

Establishment of an induced pluripotent stem cell line ZZUi003-A from a 65-year-old male with sporadic Parkinson's disease
by: Xiangyu Zheng, et al.
Published: (2017-08-01)

Generation of a human induced pluripotent stem cell (iPSC) line (IBMS-iPSC-057-05) from a patient with familial parkinsonism and polyneuropathy having a heterozygous p.Y314S mutation in UQCRC1 gene
by: Chih-Hsin Ou-Yang, et al.
Published: (2020-12-01)

Generation of a human induced pluripotent stem cell (iPSC) line (IBMS-iPSC-048-05) from a patient with ALS and parkinsonism having a hexanucleotide repeat expansion mutation in C9orf72 gene
by: Han-Yi Lin, et al.
Published: (2020-04-01)

Generation of an integration-free iPSC line(SYSUi001-A) from a sporadic Alzheimer's disease patient
by: Rui Wei, et al.
Published: (2019-03-01)

Establishment of induced pluripotent stem cell (iPSC) line from an 84-year old patient with late onset Alzheimer's disease (LOAD)
by: Zsuzsanna Táncos, et al.
Published: (2016-07-01)

Generation of an integration-free induced pluripotent stem cell (iPSC) line (ZZUNEUi001-A) from a healthy male individual
by: Jiwei Zhang, et al.
Published: (2020-05-01)

Integrity of Induced Pluripotent Stem Cell (iPSC) Derived Megakaryocytes as Assessed by Genetic and Transcriptomic Analysis.
by: Kai Kammers, et al.
Published: (2017-01-01)

Design of a Tumorigenicity Test for Induced Pluripotent Stem Cell (iPSC)-Derived Cell Products
by: Shin Kawamata, et al.
Published: (2015-01-01)

Generation of SCN1A Knock out induced pluripotent stem cell (iPSC) line
by: Wei Shan, et al.
Published: (2021-08-01)

iPSC for modeling neurodegenerative disorders
by: Valeria Valadez-Barba, et al.
Published: (2020-12-01)

Maturing iPSC-Derived Cardiomyocytes
by: Bor Luen Tang
Published: (2020-01-01)

iPSC Bioprinting: Where are We at?
by: Sara Romanazzo, et al.
Published: (2019-08-01)

Establishment of induced pluripotent stem cell (iPSC) line from a 63-year old patient with late onset Alzheimer's disease (LOAD)
by: Abinaya Chandrasekaran, et al.
Published: (2016-07-01)

Generation of induced pluripotent stem cell (iPSC) line from a 21-year-old X-linked adrenoleukodystrophy (X-ALD) patient
by: Young Rang You, et al.
Published: (2017-12-01)

Establishment of induced pluripotent stem cell (iPSC) line from a 75-year old patient with late onset Alzheimer's disease (LOAD)
by: Zsuzsanna Táncos, et al.
Published: (2016-07-01)

Generation of iPSC line from a Parkinson patient with PARK7 mutation and CRISPR-edited Gibco human episomal iPSC line to mimic PARK7 mutation
by: Melissa Conti Mazza, et al.
Published: (2021-08-01)

Integration-free T cell-derived human induced pluripotent stem cells (iPSCs) from a healthy individual: WT-iPSC1
by: Munenari Itoh, et al.
Published: (2016-07-01)

Integration-free T cell-derived human induced pluripotent stem cells (iPSCs) from a healthy individual: WT-iPSC4
by: Munenari Itoh, et al.
Published: (2016-07-01)

Integration-free T cell-derived human induced pluripotent stem cells (iPSCs) from a healthy individual: WT-iPSC2
by: Munenari Itoh, et al.
Published: (2016-07-01)

Optimizing maturity and dose of iPSC-derived dopamine progenitor cell therapy for Parkinson’s disease
by: Brundin, P., et al.
Published: (2022)

Generation and characterization of four Chediak-Higashi Syndrome (CHS) induced pluripotent stem cell (iPSC) lines
by: Jenny Serra-Vinardell, et al.
Published: (2020-08-01)

Induced Pluripotent Stem Cell (iPSC)-Based Neurodegenerative Disease Models for Phenotype Recapitulation and Drug Screening
by: Chia-Yu Chang, et al.
Published: (2020-04-01)

Transcriptome Analysis of Induced Pluripotent Stem Cell (iPSC)-derived Pancreatic β-like Cell Differentiation
by: Yan Huang, et al.
Published: (2017-08-01)

Genetics of Two Mendelian Traits and Validation of Induced Pluripotent Stem Cell (iPSC) Technology for Disease Modeling
by: Raykova, Doroteya
Published: (2015)

Modeling chemotherapy induced neurotoxicity with human induced pluripotent stem cell (iPSC) -derived sensory neurons
by: Christian Schinke, et al.
Published: (2021-07-01)